Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists.

García-Doval I, Pérez-Zafrilla B, Descalzo MA, Roselló R, Hernández MV, Gómez-Reino JJ, Carmona L; BIOBADASER 2.0 Study Group.

Ann Rheum Dis. 2010 Oct;69(10):1751-5. doi: 10.1136/ard.2009.125658. Epub 2010 Jun 15.


Zoster vaccine: current status and future prospects.

Oxman MN.

Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605. Review.


Yellow fever revaccination during infliximab therapy.

Scheinberg M, Guedes-Barbosa LS, Mangueira C, Rosseto EA, Mota L, Oliveira AC, Lima RA.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):896-8. doi: 10.1002/acr.20045. No abstract available.


Effectiveness of varicella vaccine in children infected with HIV.

Son M, Shapiro ED, LaRussa P, Neu N, Michalik DE, Meglin M, Jurgrau A, Bitar W, Vasquez M, Flynn P, Gershon AA.

J Infect Dis. 2010 Jun 15;201(12):1806-10. doi: 10.1086/652798.


Barriers to the use of herpes zoster vaccine.

Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, Dong F, Beaty BL, Tan L, Babbel C, Dickinson LM, Kempe A.

Ann Intern Med. 2010 May 4;152(9):555-60. doi: 10.7326/0003-4819-152-9-201005040-00005.


A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.

Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P; Pediatric AIDS Clinical Trials Group 391 Team.

Pediatr Infect Dis J. 2009 Jul;28(7):653-5. doi: 10.1097/INF.0b013e3181998f06.


Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.

Oxman MN.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7. Review.


Herpes zoster in the age of focused immunosuppressive therapy.

Whitley RJ, Gnann JW Jr.

JAMA. 2009 Feb 18;301(7):774-5. doi: 10.1001/jama.2009.150. No abstract available. Erratum in: JAMA. 2010 Feb 24;303(8):734.


Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.

Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.

JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.


Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA.

Neurol Clin. 2008 Aug;26(3):675-97, viii. doi: 10.1016/j.ncl.2008.03.011. Review.


Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.


American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE; American College of Rheumatology.

Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721. No abstract available.


Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.

Wood SM, Shah SS, Steenhoff AP, Rutstein RM.

Pediatrics. 2008 Jan;121(1):e150-6. Epub 2007 Dec 17.


The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.

Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.

Arthritis Rheum. 2007 Dec 15;57(8):1431-8.


A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS.

Mayo Clin Proc. 2007 Nov;82(11):1341-9. Erratum in: Mayo Clin Proc. 2008 Feb;83(2):255.


Immunizations in older adults.

High K.

Clin Geriatr Med. 2007 Aug;23(3):669-85, viii-ix. Review.


The incidence of herpes zoster in a United States administrative database.

Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA.

J Gen Intern Med. 2005 Aug;20(8):748-53.


A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.


Incidence of herpes zoster, 1997-2002.

Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H.

Epidemiol Infect. 2005 Apr;133(2):245-53.


Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK.

Am J Transplant. 2004 Jan;4(1):108-15.

Supplemental Content

Support Center